These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6011765)

  • 1. [The importance of the inactivation of phthivazid in the mechanism of resistance to it in Mycobacterium tuberculosis].
    Smirnov AG
    Ter Arkh; 1966 Aug; 38(8):28-32. PubMed ID: 6011765
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phythyvazid-resistance of myobacterium tuberculosis and its clinical importance].
    Belogurova VP; Dargevich VK
    Sov Med; 1966 Mar; 29(3):66-72. PubMed ID: 4967965
    [No Abstract]   [Full Text] [Related]  

  • 3. [Resistance of Mycobacterium tuberculosis, the extent of isoniazid inactivation and blood bacteriostatic activity in chemotherapy of pulmonary tuberculosis].
    Tipp ZI
    Probl Tuberk; 1969; 47(8):76-9. PubMed ID: 4987468
    [No Abstract]   [Full Text] [Related]  

  • 4. [The epidemiological and clinical significance of the drug resistance of Mycobacterium tuberculosis].
    Luk'ianov NG
    Probl Tuberk; 1967; 45(3):8-12. PubMed ID: 5629329
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative data on the tolerance of phthivazid, methazid and tubazid in patients with pulmonary tuberculosis].
    Stepanian ES
    Vrach Delo; 1965 Oct; 10():8-10. PubMed ID: 5896073
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of inactivation of phthivazid in the therapy of tuberculosis in children].
    Aminov NR
    Probl Tuberk; 1965; 43(8):29-33. PubMed ID: 5296614
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistant mycobacterium tuberculosis: report of a family in Connecticut.
    Gerstenhaber BJ
    Conn Med; 1980 Jul; 44(7):416-8. PubMed ID: 6772373
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative significance of methods of detection of Mycobacterium tuberculosis in pathological material from patients under prolonged antibacterial therapy].
    Brudnaia KB; Slepova RI; Borovkova NM
    Lab Delo; 1968; 5():296-9. PubMed ID: 4185823
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems of therapeutic management of patients with pulmonary tuberculosis excreting tuberculous mycobacteria resistent to streptomycin and phthivazid].
    Vinnik LA
    Probl Tuberk; 1966; 44(6):23-7. PubMed ID: 4968673
    [No Abstract]   [Full Text] [Related]  

  • 10. Cycloserine in the treatment of pulmonary tuberculosis.
    Bumbacescu N
    Scand J Respir Dis Suppl; 1970; 71():115-9. PubMed ID: 5271970
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative evaluation of antimicrobial properties of actinomyces isolated from the patients with pulmonary tuberculosis, treated with phthivazid and streptomycin].
    Nikiforchin RN
    Probl Tuberk; 1971; 49(7):66-71. PubMed ID: 5170738
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of antimicrobial properties of actinomyces, isolated in patients with pulmonary tuberculosis treated with phthivazid and streptomycin].
    Nikiforchin RN
    Probl Tuberk; 1971; 49(7):66-71. PubMed ID: 5169485
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-resistance tuberculosis among the foreign-born in Canada.
    Can Commun Dis Rep; 2005 Feb; 31(4):46-52. PubMed ID: 15712449
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary drug resistance of Mycobacterium tuberculosis in pulmonary tuberculosis].
    Egorova NG; Mel'nikov EL
    Probl Tuberk; 1971; 49(1):56-8. PubMed ID: 5576513
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of the treatment of pulmonary tuberculosis with INAH preparations in different degrees of tubazid inactivation].
    Kagramanov AI; Ezerskiĭ VF; Ezerskaia EN; Kiroshka IZ; Grigorian VG
    Sov Med; 1973 Jul; 36(7):82-4. PubMed ID: 4776714
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inactivation of INH and effectiveness of chemotherapy in pulmonary tuberculosis].
    Gipp ZI
    Vrach Delo; 1974 Jan; (1):104-5. PubMed ID: 4468550
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aerosol therapy of pulmonary tuberculosis with differing degrees of resistance to GINK preparations].
    Kulik NM
    Probl Tuberk; 1972; 50(11):78-9. PubMed ID: 4647624
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The problem of infectiousness of tuberculosis patients during chemotherapy].
    Schulthess HK; Zollikofer H
    Schweiz Med Wochenschr; 1981 Feb; 111(8):251-4. PubMed ID: 6785880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.